Early research (Phase 1)Ended earlyNCT00054834What this trial is testingStudy of 90Y-hLL2 to Treat Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkins Lymphoma Gilead Sciences 27
Testing effectiveness (Phase 2)Study completedNCT01980654What this trial is testingStudy of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular LymphomaWho this might be right forFollicular LymphomaB-cell LymphomaNon-Hodgkin's Lymphoma Pharmacyclics LLC. 80
Very early researchActive Not RecruitingNCT07585851What this trial is testingAdministration of Repurposed Ketoconazole in Glioma PatientsWho this might be right forDiffuse GliomaDiffuse Glioma, Grade IDiffuse Glioma, Grade II+2 more Universitas Padjadjaran 80
Not applicableActive Not RecruitingNCT04567394What this trial is testingCannabis Use Disorder Treatment StudyWho this might be right forCannabis Use Disorder, MildCannabis Use Disorder, ModerateCannabis Use Disorder, Severe The University of Tennessee, Knoxville 1,077
Testing effectiveness (Phase 2)Study completedNCT00001873What this trial is testingThe Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood CancersWho this might be right forChronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more National Heart, Lung, and Blood Institute (NHLBI) 102
Large-scale testing (Phase 3)Study completedNCT01686594What this trial is testingPUVA Maintenance Therapy in Mycosis FungoidesWho this might be right forPatch/Plaque Stage Mycosis Fungoides Medical University of Graz 28
Early research (Phase 1)Looking for participantsNCT06815029What this trial is testingIntracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaWho this might be right forRecurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma City of Hope Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT00535470What this trial is testingAn Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis FungoidesWho this might be right forMycosis Fungoides Yaupon Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT00609869What this trial is testingLenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After RituximabWho this might be right forLymphocytic LeukemiaMantle Cell Lymphoma H. Lee Moffitt Cancer Center and Research Institute 29
Testing effectiveness (Phase 2)UnknownNCT06503094What this trial is testingCD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological TumorsWho this might be right forB-Cell Lymphoblastic Leukemia/Lymphoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Testing effectiveness (Phase 2)Looking for participantsNCT05800366What this trial is testingA Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell LymphomaWho this might be right forLymphomaLymphoma, Large B-Cell, Diffuse Jennifer Crombie, MD 41
Early research (Phase 1)WithdrawnNCT06290622What this trial is testingPD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCLWho this might be right forDiffuse Large B Cell LymphomaLymphoma, B-CellLymphoma, Follicular University of Alabama at Birmingham
Early research (Phase 1)UnknownNCT05487651What this trial is testingAllogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell MalignanciesWho this might be right forNHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more Athenex, Inc. 36
Not applicableLooking for participantsNCT07011966What this trial is testingASV Therapy for InsomniaWho this might be right forInsomniaInsomnia (Moderate) ResMed 25
Early research (Phase 1)Study completedNCT00275080What this trial is testingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07639879What this trial is testingTR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell LymphomaWho this might be right forPTCLNK T-Cell Lymphoma Tarapeutics Science Inc. 180
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Not applicableStudy completedNCT00006342What this trial is testingGenetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain TumorWho this might be right forBrain and Central Nervous System TumorsLymphoma Duke University 19
Not applicableStudy completedNCT02488369What this trial is testingDiagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and AdolescentsWho this might be right forNon-Hodgkin Lymphoma Gustave Roussy, Cancer Campus, Grand Paris 230